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wedical literature has recently focused on very late
tent thrombosis (VLST) after drug-eluting stent
mplantation, while its mechanistic issue was not
ully explored in the bare-metal stent (BMS) era.
he first case is a 59-year-old man presenting with
nferior non–ST-segment elevation myocardial in-
arction, 4 years after BMS implantation (NIR
.5/18 mm, Boston Scientific, Galway, Ireland) for
chronic total occlusion lesion in the proximal
ight coronary artery. Coronary angiograms
howed Thrombolysis In Myocardial Infarction
rom the *Division of Cardiology, Nippon Medical School, Tokyo,
apan; and †Cardiovascular Center, Chiba-Hokusoh Hospital, Nippon
edical School, Tokyo, Japan.
1. Findings of Coronary Angiography and Angioscopy
ronary angiograms show Thrombolysis In Myocardial Infarction (TIM
d thrombi (arrows) and uncovered stent struts (arrowhead) are ide
nt segment (arrowheads). Ruptured yellow plaque (arrow) and thr
view. *Guidewire.anuscript received May 27, 2009; revised manuscript received August
1, 2009, accepted August 20, 2009.TIMI) flow grade 1 and filling defects in the BMS
eployed previously, and massive red thrombi at-
aching to uncovered stent struts were found by
ngioscope (Fig. 1, Online Video 1). Thrombec-
omy and adjunctive balloon angioplasty were per-
ormed based on the angioscopic findings, and
IMI flow grade 3 was obtained. The second case
s a 71-year-old man who was admitted for a
iagnosis of inferior non–ST-segment elevation
yocardial infarction 10 years after a treatment
ith BMS (gfx 3.0/18 mm, Applied Vascular
grade 1 with ﬁlling defects of the stent segment. In this segment, o
by angioscope. (B) Angiograms show TIMI ﬂow grade 3 and hazine
are found by angioscope. Any stent struts are not visible in this angFigure
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1287ngineering, Santa Rosa, California) for the culprit lesion
f stable angina pectoris in the distal right coronary artery.
ngiographic haziness in the BMS segment was seen
espite of TIMI flow grade 3. Any progressive lesions on
ngiogram were not seen in other segments. Angioscopic
bservation for the stent segment demonstrated absence of
he uncovered struts. Remarkably, ruptured yellow plaque
ccompanied by thrombi occupied the lumen (Fig. 1,
nline Video 2). Direct stenting was consequently per-
ormed for sealing the ruptured plaque. Although both cases
ere definite VLST standardized by the Academic Re-
earch Consortium (1), lumen appearance of direct visual-
zation by angioscope was quite different. Previous autopsy
tudies showed that plaque disruption outside the BMS
ith extensive prolapse could lead to thrombosis (2). For the
rst time, angioscopic findings in the second case propose
trong evidence that atherosclerotic plaque disruption inside
he BMS may be one potential trigger of thrombosis.
owever, persistent uncovered struts in the first case may
ead to VLST, as well as those of the drug-eluting stent (3).
he present images cannot generalize VLST to all cases. Fowever, contrastive angioscopic images suggest that vari-
us pathogeneses may contribute to the occurrence of
efinite VLST after BMS implantation, and different in-
erventional strategies for VLST may be chosen.
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APPENDIXor accompanying videos, please see the online version of this article.
